Talampicillin
- J01CA15 (WHO)
- 3-oxo-1,3-dihydro-2-benzofuran-1-yl (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
- 47747-56-8 Y
- 5373
- 64529 N
- 29OJI73DPC
- ChEMBL1322719 N
- DTXSID1048540
- Interactive image
- O=C(OC2OC(=O)c1ccccc12)[C@@H]4N5C(=O)[C@@H](NC(=O)[C@@H](c3ccccc3)N)[C@H]5SC4(C)C
- InChI=1S/C24H23N3O6S/c1-24(2)17(22(31)33-23-14-11-7-6-10-13(14)21(30)32-23)27-19(29)16(20(27)34-24)26-18(28)15(25)12-8-4-3-5-9-12/h3-11,15-17,20,23H,25H2,1-2H3,(H,26,28)/t15-,16-,17+,20-,23?/m1/s1 N
- Key:SOROUYSPFADXSN-SUWVAFIASA-N N
Talampicillin is a beta lactam antibiotic from the penicillin family. It is an acid stable prodrug that was administered orally. It is not approved by the FDA for use in the United States. It should be avoided in Liver diseases
Synthesis
Ampicillin remains the penicillin of choice for many infections because of its oral activity and good potency against Gram-negative bacteria. A number of prodrugs have been examined in attempts to improve upon the pharmacodynamic characteristics, and one of these is talampicillin.
One synthesis involved protecting the primary amino group of ampicillin (1) as the enamine with ethyl acetoacetate (2). THis was then esterified by reaction with 3-bromopthalide (3), and the enamine was carefully hydrolyzed with dilute HCl in acetonitrile to produce talampicillin (4).[citation needed]
References
- ^ Isaka I, Nakano K, Kashiwagi T, Koda A, Horiguchi H (January 1976). "Lactol esters of ampicillin". Chemical & Pharmaceutical Bulletin. 24 (1): 102–7. doi:10.1248/cpb.24.102. PMID 1269054.
- ^ Clayton JP, Cole M, Elson SW, Ferres H, Hanson JC, Mizen LW, Sutherland R (December 1976). "Preparation, hydrolysis, and oral absorption of lactonyl esters of penicillins". Journal of Medicinal Chemistry. 19 (12): 1385–91. doi:10.1021/jm00234a007. PMID 826629.
- ^ DE 2228012, Ferres H, Clayton MP, "Phthalide penicillin ester intermediates", issued 1972, assigned to Beecham
- ^ US 3860579, Ferres H, Clayton MP, "Phthalide Peniclillin Ester and Salts", issued 1975, assigned to Beecham
- ^ US 3951954, Murakami, "Novel oxofuryl ester derivatives of penicillin and cephalosporin", issued 1976, assigned to Yamanouchi
- v
- t
- e
(inhibit synthesis
of peptidoglycan
layer of bacterial
cell wall by binding
to and inhibiting
PBPs, a group of
D-alanyl-D-alanine
transpeptidases)
Glycopeptides Lipoglycopeptides |
|
---|---|
Lipopeptides |
|
Polymyxins |
|
Other |
|
- Inhibit PG subunit synthesis and transport: NAM synthesis inhibition (Fosfomycin)
- DADAL/AR inhibitors (Cycloserine)
- bactoprenol inhibitors (Bacitracin)
- Hydrolyze NAM-NAG
- Tyrothricin
- Isoniazid#
- Teixobactin
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e